REGENXBIO Inc. (RGNX) financial statements (2022 and earlier)

Company profile

Business Address 9804 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
State of Incorp.
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:849523400471176159216
Cash and cash equivalents3453387076472554
Short-term investments1121372272441146560
Other undisclosed cash, cash equivalents, and short-term investments392471041511669102
Receivables3243389012
Prepaid expense191166521
Other current assets10244111
Other undisclosed current assets(392)(47)(104)(151)(16)(69)(102)
Total current assets:51953134533816893118
Noncurrent Assets
Operating lease, right-of-use asset616410
Property, plant and equipment1325629291491
Long-term investments and receivables394501081741669103
Long-term investments392471041511669103
Accounts and financing receivable, after allowance for credit loss23423   
Restricted cash and investments211100 
Other noncurrent assets6552100
Total noncurrent assets:5951771532063179103
TOTAL ASSETS:1,114708498544199173221
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities432718151153
Accounts payable111164521
Accrued liabilities1000001
Employee-related liabilities2013119631
Taxes payable113 1   
Deferred revenue30 
Debt  2    
Customer advances and deposits  0
Contract with customer, liability1
Other undisclosed current liabilities8454147451
Total current liabilities:13081342214104
Noncurrent Liabilities
Long-term debt and lease obligation85709    
Operating lease, liability85709
Liabilities, other than long-term debt1457110
Deferred revenue and credits110
Deferred revenue 43
Contract with customer, liability3
Deferred rent credit   1
Other liabilities1123   
Other undisclosed noncurrent liabilities133175 6   
Total noncurrent liabilities:2192491413110
Total liabilities:350330483516115
Stockholders' equity
Stockholders' equity attributable to parent764378450509183162217
Common stock0000000
Additional paid in capital928667628593371276269
Accumulated other comprehensive income (loss)(3)(0)0(1)(1)(0)(1)
Accumulated deficit(161)(289)(178)(83)(188)(115)(52)
Total stockholders' equity:764378450509183162217
TOTAL LIABILITIES AND EQUITY:1,114708498544199173221

Income statement (P&L) ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues470155352191058
Revenue, net1058
Cost of revenue(52)(44)(8)(10)(2)(1)(2)
Cost of goods and services sold(52)(36)(8) (2)(1)(2)
Gross profit:41911127209946
Operating expenses(261)(230)(176)(121)(84)(69)(29)
Other operating income (expense), net  0(0)(0)0 
Other undisclosed operating income2  00  
Operating income (loss):160(119)(149)88(76)(65)(23)
Nonoperating income (expense)(19)135216320
Investment income, nonoperating71049732 
Other nonoperating income      0
Interest and debt expense(26)(1)    (0)
Income (loss) from continuing operations before equity method investments, income taxes:115(107)(97)104(73)(63)(23)
Other undisclosed income from continuing operations before income taxes261     
Income (loss) from continuing operations before income taxes:141(106)(97)104(73)(63)(23)
Income tax expense (benefit)(13)(5)3(4) 0 
Net income (loss):128(111)(95)100(73)(63)(23)
Other undisclosed net income attributable to parent      0
Net income (loss) attributable to parent:128(111)(95)100(73)(63)(23)
Preferred stock dividends and other adjustments      (2)
Other undisclosed net income available to common stockholders, basic      1
Net income (loss) available to common stockholders, diluted:128(111)(95)100(73)(63)(24)

Comprehensive Income ($ in millions)

12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net income (loss):128(111)(95)100(73)(63)(23)
Other comprehensive income (loss)(2)(1)1(0)(1)1(1)
Comprehensive income (loss):126(112)(94)100(74)(62)(24)
Other undisclosed comprehensive income, net of tax, attributable to parent      0
Comprehensive income (loss), net of tax, attributable to parent:126(112)(94)100(74)(62)(24)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: